EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 40 / Numéro 4 (Avril 2024) Med Sci (Paris), 40 4 (2024) 361-368 Références
Open Access
Numéro
Med Sci (Paris)
Volume 40, Numéro 4, Avril 2024
Page(s) 361 - 368
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2024039
Publié en ligne 23 avril 2024
  1. Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Disease primers 2018 ; 4 : 17105. [CrossRef] [Google Scholar]
  2. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011 ; 12 : 489–495. [CrossRef] [PubMed] [Google Scholar]
  3. Ferrer M, Anthony TG, Ayres JS, et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell 2023; 186 : 1824–45. [CrossRef] [PubMed] [Google Scholar]
  4. Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell metab 2012 ; 16 : 153–166. [CrossRef] [PubMed] [Google Scholar]
  5. Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 2016 ; 5 : e200. [CrossRef] [PubMed] [Google Scholar]
  6. Ferrara M, Samaden M, Ruggieri E, Venereau E. Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene. Front Cell Dev Biol 2022; 10 : 960341. [CrossRef] [PubMed] [Google Scholar]
  7. Wyart E, Bindels LB, Mina E, et al. Cachexia, a Systemic Disease beyond Muscle Atrophy. Int J Mol Sci 2020; 21 : 8592. [CrossRef] [PubMed] [Google Scholar]
  8. Fonseca G, Farkas J, Dora E, et al. Cancer Cachexia and Related Metabolic Dysfunction. Int J Mol Sci 2020; 21 : 2321. [CrossRef] [PubMed] [Google Scholar]
  9. Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep 2019 ; 20. [Google Scholar]
  10. Fang R, Yan L, Liao Z. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Front Oncol 2023; 13 : 1123567. [Google Scholar]
  11. Setiawan T, Sari IN, Wijaya YT, et al. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol 2023; 16 : 54. [CrossRef] [PubMed] [Google Scholar]
  12. Talbert EE, Cuitino MC, Ladner KJ, et al. Modeling Human Cancer-induced Cachexia. Cell Rep 2019 ; 28 : 1612–22.e4. [Google Scholar]
  13. Paval DR, Patton R, McDonald J, et al. A systematic review examining the relationship between cytokines and cachexia in incurable cancer. J Cachexia Sarcopenia Muscle 2022; 13 : 824–38. [CrossRef] [PubMed] [Google Scholar]
  14. Kadakia KC, Hamilton-Reeves JM, Baracos VE. Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach. Am Soc Clin Oncol Educ Book 2023; 43 : e389942. [CrossRef] [PubMed] [Google Scholar]
  15. Argiles JM, Stemmler B, Lopez-Soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol 2018 ; 15 : 9–20. [Google Scholar]
  16. Martin A, Gallot YS, Freyssenet D. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies. J Cachexia Sarcopenia Muscle 2023; 14 : 1150–67. [CrossRef] [PubMed] [Google Scholar]
  17. Flint TR, Janowitz T, Connell CM, et al. Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity. Cell metab 2016 ; 24 : 672–684. [CrossRef] [PubMed] [Google Scholar]
  18. Daas SI, Rizeq BR, Nasrallah GK. Adipose tissue dysfunction in cancer cachexia. J Cell Physiol 2018 ; 234 : 13–22. [Google Scholar]
  19. Weber BZC, Arabaci DH, Kir S. Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia. Front Oncol 2022; 12 : 848394. [Google Scholar]
  20. Molfino A, Imbimbo G, Muscaritoli M. Metabolic and histomorphological changes of adipose tissue in cachexia. Curr Opin Clin Nutr Metab Care 2023; 26 : 235–42. [CrossRef] [PubMed] [Google Scholar]
  21. Petruzzelli M, Schweiger M, Schreiber R, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell metab 2014 ; 20 : 433–447. [CrossRef] [PubMed] [Google Scholar]
  22. Tsoli M, Moore M, Burg D, et al. Activation of thermogenesis in brown adipose tissue and dysregulated lipid metabolism associated with cancer cachexia in mice. Cancer res 2012 ; 72 : 4372–4382. [CrossRef] [PubMed] [Google Scholar]
  23. Das SK, Eder S, Schauer S, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 2011 ; 333 : 233–238. [CrossRef] [PubMed] [Google Scholar]
  24. Engineer DR, Garcia JM. Leptin in anorexia and cachexia syndrome. Int J Pept 2012 ; 2012 : 287457. [CrossRef] [Google Scholar]
  25. Mannelli M, Gamberi T, Magherini F, Fiaschi T. The Adipokines in Cancer Cachexia. Int J Mol Sci 2020; 21. [PubMed] [Google Scholar]
  26. Panebianco C, Villani A, Potenza A, et al. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options. International journal of molecular sciences 2023; 24. [PubMed] [Google Scholar]
  27. McDonald J, Sayers J, Anker SD, et al. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle 2023; 14 : 1932–48. [CrossRef] [PubMed] [Google Scholar]
  28. Sayers J, Skipworth RJ, Laird BJ. Cancer cachexia - adopting a systems wide approach. Curr Opin Clin Nutr Metab Care 2023; 26 : 393–8. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.